JP2010525073A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010525073A5 JP2010525073A5 JP2010506460A JP2010506460A JP2010525073A5 JP 2010525073 A5 JP2010525073 A5 JP 2010525073A5 JP 2010506460 A JP2010506460 A JP 2010506460A JP 2010506460 A JP2010506460 A JP 2010506460A JP 2010525073 A5 JP2010525073 A5 JP 2010525073A5
- Authority
- JP
- Japan
- Prior art keywords
- mglur7
- modulator
- use according
- medicament
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100038294 Metabotropic glutamate receptor 7 Human genes 0.000 claims 4
- 108010038449 metabotropic glutamate receptor 7 Proteins 0.000 claims 4
- 206010011878 Deafness Diseases 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 231100000888 hearing loss Toxicity 0.000 claims 2
- 230000010370 hearing loss Effects 0.000 claims 2
- 208000016354 hearing loss disease Diseases 0.000 claims 2
- YRQCDCNQANSUPB-UHFFFAOYSA-N AMN082 dihydrochloride Chemical group Cl.Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)NCCNC(C=1C=CC=CC=1)C1=CC=CC=C1 YRQCDCNQANSUPB-UHFFFAOYSA-N 0.000 claims 1
- 206010036626 Presbyacusis Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91352007P | 2007-04-23 | 2007-04-23 | |
| US488007P | 2007-11-30 | 2007-11-30 | |
| US2100708P | 2008-01-14 | 2008-01-14 | |
| PCT/US2008/061330 WO2008131439A1 (en) | 2007-04-23 | 2008-04-23 | Treatment and/or prevention of presbycusis by modulation of metabotropic glutamate receptor 7 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010525073A JP2010525073A (ja) | 2010-07-22 |
| JP2010525073A5 true JP2010525073A5 (enExample) | 2011-06-02 |
Family
ID=39580582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506460A Pending JP2010525073A (ja) | 2007-04-23 | 2008-04-23 | 代謝型グルタミン酸受容体７の調節による老人性難聴の治療及び／又は予防 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20100197800A1 (enExample) |
| EP (1) | EP2150244A1 (enExample) |
| JP (1) | JP2010525073A (enExample) |
| WO (1) | WO2008131439A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| BRPI0910850B1 (pt) | 2008-04-21 | 2022-06-14 | Otonomy, Inc. | Composição intratimpânica compreendendo fator neurotrófico de crescimento derivado do cérebro (bdnf) para o tratamento ou prevenção da perda auditiva |
| WO2009139924A2 (en) | 2008-05-14 | 2009-11-19 | Otonomy, Inc. | Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| US8846770B2 (en) | 2008-06-18 | 2014-09-30 | Otonomy, Inc. | Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders |
| WO2010011466A2 (en) | 2008-06-27 | 2010-01-28 | Otonomy, Inc. | Controlled-release cns modulating compositions and methods for the treatment of otic disorders |
| US8496957B2 (en) * | 2008-07-21 | 2013-07-30 | Otonomy, Inc | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| US8784870B2 (en) | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
| US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| AU2009307825A1 (en) | 2008-10-22 | 2010-04-29 | Rick FRIEDMAN | Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| WO2015031393A1 (en) | 2013-08-27 | 2015-03-05 | Otonomy, Inc. | Treatment of pediatric otic disorders |
| WO2015120453A1 (en) * | 2014-02-10 | 2015-08-13 | University Of South Florida | Hormone treatment for age-related hearing loss-presbycusis |
| EP3459939A1 (en) | 2017-09-26 | 2019-03-27 | Pragma Therapeutics | Novel heterocyclic compounds as modulators of mglur7 |
| GB202106872D0 (en) | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202106871D0 (en) | 2021-05-13 | 2021-06-30 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202216963D0 (en) | 2022-11-14 | 2022-12-28 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202216960D0 (en) | 2022-11-14 | 2022-12-28 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202216962D0 (en) | 2022-11-14 | 2022-12-28 | Addex Pharmaceuticals Sa | Novel compounds |
| KR102847157B1 (ko) | 2023-01-17 | 2025-08-20 | 고려대학교 산학협력단 | 글루타민을 유효성분으로 포함하는 난청 예방 또는 치료용 약학 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6800651B2 (en) * | 2000-02-03 | 2004-10-05 | Eli Lilly And Company | Potentiators of glutamate receptors |
| US7507836B2 (en) * | 2003-03-26 | 2009-03-24 | Merck & Co. Inc. | Benzamide modulators of metabotropic glutamate receptors |
| US20060074083A1 (en) * | 2004-10-05 | 2006-04-06 | Merz Pharma Gmbh & Co. Kgaa | Cyclic and acyclic propenones for treating CNS disorders |
| CN101128435A (zh) * | 2004-12-27 | 2008-02-20 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物 |
| AU2006279034A1 (en) * | 2005-08-05 | 2007-02-15 | Astrazeneca Ab | Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| CN101309905A (zh) * | 2005-08-12 | 2008-11-19 | 阿斯利康(瑞典)有限公司 | 取代的异吲哚酮及其作为代谢型谷氨酸受体增效剂的用途 |
| GB0517740D0 (en) * | 2005-08-31 | 2005-10-12 | Novartis Ag | Organic compounds |
| TW200819458A (en) * | 2006-06-23 | 2008-05-01 | Merz Pharma Gmbh & Co Kgaa | Metabotropic glutamate receptor modulators |
-
2008
- 2008-04-23 WO PCT/US2008/061330 patent/WO2008131439A1/en not_active Ceased
- 2008-04-23 US US12/597,054 patent/US20100197800A1/en not_active Abandoned
- 2008-04-23 EP EP08746706A patent/EP2150244A1/en not_active Ceased
- 2008-04-23 JP JP2010506460A patent/JP2010525073A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010285439A5 (enExample) | ||
| BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
| IL199187A (en) | Indole history, pharmaceuticals including them and their use in the manufacture of medicines | |
| IL234166B (en) | Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine | |
| IL233677A (en) | Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition | |
| JP2007527914A5 (enExample) | ||
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| JP2011511805A5 (enExample) | ||
| WO2007135193A3 (fr) | Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool | |
| PL1998762T3 (pl) | Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku | |
| CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
| IL206952A (en) | History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines | |
| WO2009133352A3 (en) | Lipid composition | |
| FR2934156B1 (fr) | Medicament appetissant a administration orale sous forme solide | |
| BRPI0818680A2 (pt) | composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica | |
| BRPI0814666A2 (pt) | composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida | |
| BRPI0807285A2 (pt) | "composição, método para preparar composição farmacêutica, forma unitária de dosagem, método para admnistrar um agente biologicamente ativo a um animal necessitando o agente, método para aumentar a biodisponibilidade de um agente biologicamente ativo, método para preparar uma composição e composto" | |
| IL191310A (en) | A variant of the factor xa enhancer hemostasis, a pharmaceutical product containing it, and its use in the preparation of drugs for the treatment of hemostasis-related diseases | |
| BR112012003280A2 (pt) | composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto. | |
| EP2015740A4 (en) | NEW LOW-DOSED PHARMACEUTICAL COMPOSITIONS WITH NIMESULID, PREPARATION AND USE | |
| IL201730A (en) | History 1h - Benzaimidazole – 2 – Il – Profile – Methyl – Amino – Ethyl – 5 – Aryl – Bicyclo [2.2.2] Oct – 5 – Ann – 2 – All, Pharmaceutical preparations containing them and their use in the preparation of drugs | |
| EA201170512A1 (ru) | Композиция для перорального введения | |
| DK2083638T3 (da) | Smagsfrigivende kerner og deres anvendelse i tyggegummi | |
| WO2009064681A3 (en) | Liquid compositions comprising valsartan | |
| WO2008048674A3 (en) | Materials leading to improved dental composites and dental composites made therefrom |